PredictImmune to exhibit at the British Society of Gastroenterology Annual Meeting in Liverpool, June 5-6, 2018
Developer of prognostic tools to guide treatment of patients with immune-mediated diseases will be available at stand A176.
Cambridge, UK 31 May 2018: PredictImmune is excited to announce that it will exhibit at the British Society of Gastroenterology (BSG) annual meeting on the 5th and 6th of June to coincide with the inflammatory bowel disease (IBD) sessions. This is a great opportunity for PredictImmune to showcase the latest news on the development of its new prognostic biomarker test for treatment guidance in Crohn’s disease, one of the major forms of IBD. Drs Paul Lyons and Karen Hills from PredictImmune look forward to meeting you at the stand and answering your questions.
PredictImmune is a start-up company based in Cambridge, UK. It develops pioneering tools to guide treatment decision-making in immune-mediated inflammatory diseases. The company’s first product will be a biomarker test for Inflammatory Bowel Disease (both Crohn’s disease and ulcerative colitis), which accurately predicts disease course from diagnosis. The test, which is expected to be available towards the end of 2018, is based on pioneering research from the University of Cambridge. It is expected to facilitate optimisation of treatment pathways, improving outcomes and quality of life for patients and potentially reducing the overall cost of treating IBD.
The BSG annual meeting will also feature presentations focused on prognosis in Crohn’s disease from members of the University of Cambridge team. Please attend the following to find out more:
Dr. Nurulamin Noor,
Dr Noor will present a poster entitled ‘PROFILE biomarker: Effect of steroid treatment on a prognostic gene expression signature’
on Wednesday 6th June: paper number 79, reference PWE-042.
Dr James Lee
Dr Lee will deliver two platform presentations as follows:
Tuesday 5th June: 11:00-12:45 PM: Sir Francis Avery-Jones Lecture entitled ‘Genetics of prognosis in Crohn’s disease’.
Wednesday 5th June: 4:30-6:30 PM: ‘Predicting disease course in IBD’.